African HIV patients adhere to medication

better than American counterparts, contrary to some expectations. This means "poor adherence" cannot be used to excuse failing to provide antiretroviral drugs to poorer countries, researchers say. Meanwhile, a UN conference in Toronto hears that 1 million Africans now have access to such medications, a vast increase since 2003, but still only a quarter of the need.